ST Jiaying Co., Ltd.

2025 Annual General Meeting Materials

This document outlines the procedures and agenda for Guangdong Jiaying Pharmaceutical Co., Ltd.'s 2025 Annual General Meeting. It details shareholder rights, voting methods (online and in-person), and the specific proposals to be discussed, including the 2025 annual report, board work report, and dividend distribution plans. The meeting aims to ensure smooth operations and protect shareholder interests.

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Abnormal Stock Trading Fluctuations

Report of the Audit Committee of the Board of Directors on the Supervision Responsibilities of the Accounting Firm for 2025

Announcement on the Risk Warning of Possible Delisting of Company Stock

2025 Annual Work Report of Independent Director (Dai Ru Rong)

2025 Annual Work Report of Independent Director (Li Jun Guo)

2025 Annual Report of Independent Director (Xu Chi)

2025 Annual Report of Independent Director (Li Shanwei)

2025 Annual Report of Independent Director (Guo Huaping)

Announcement on Holding the 2025 Annual Online Performance Briefing

Internal Control Audit Report (2026) No. 03569

2025 Annual Internal Control Evaluation Report

Announcement on Changes in Accounting Policies

Announcement on Expected Daily Related Transactions for 2026

Notice on Holding the 2025 Annual Shareholders' Meeting

2025 Annual Work Report of the Board of Directors

Announcement of the Resolution of the 10th Meeting of the 7th Board of Directors

Announcement on the Proposal Not to Distribute Profits for 2025

2026 Q1 Report

Special Explanation on the Audit Opinion (Qualified) and Internal Control Audit Opinion (Negative) for Guangdong Jiaying Pharmaceutical Co., Ltd. for 2025 (2026) No. 07099

Special Explanation by the Audit Committee on Matters Related to the Qualified Audit Report and Negative Opinion Internal Control Audit Report for 2025

Special Explanation by Independent Directors on Matters Related to the Qualified Audit Report and Negative Opinion Internal Control Audit Report for 2025

Special Explanation on Matters Related to the Qualified Audit Report and Negative Opinion Internal Control Audit Report by the Board

Evaluation Report on the Performance of the Accounting Firm for 2025

Report on the Performance of the Audit Committee of the Board for 2025

Special Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions (2026) No. 03570

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for Listed Companies in 2025

Special Report on the Board's Self-Examination of the Independence of Independent Directors for 2025

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report